Translational Cancer Medicine
The Westin San Diego

San Diego, CA

Schedule of Presentations:

Monday, January 26, 2009
08:30:00 Registration for Pre-Conference Events*
09:00:00 Pre-Conference Short Course* : Novel Cancer Biomarkers
09:00:00 Chairperson’s Opening Remarks
09:05:00 in vivo Discovery and Validation of Biomarkers of Human Drug Response and Resistance Joerg Heyer
09:30:00 Preclinical Biomarker Discovery and Validation for a Small Molecule Inhibitor of MEK Kinase Mark R Lackner
09:55:00 Development of Clinically Relevant Gene Expression Profiles for Prognosis of Early Stage Breast Cancer Richard Bender
10:20:00 Networking Coffee Break
10:40:00 Circulating HER-2/neu, A Biomarker for HER-2 Positive Breast Cancer, from Discovery to Patient Management Walter Carney
11:00:00 Pre-Conference Short Course* : Fit-for-Purpose Biomarker Assay Development and Validation Jean W Lee, Viswanath Devanarayan, John Allinson
11:05:00 Discovery of miRNA-Based Biomarkers for Cancer Søren Møller
11:30:00 Lunch on your own
12:30:00 Cancer Biomarker Discovery in the Context of Personalized Medicine Josip Blonder
12:55:00 Industrialized Proteomics for the Discovery and Validation of Oncology Biomarkers Daniel Chelsky
13:20:00 Metabolite Biomarkers of Prostate Cancer Aggressivity Jeffrey Shuster
13:45:00 Networking Refreshment Break
14:10:00 From Discovery to the Clinic: The Novel DNA Methylation Biomarker, Septin 9, for the Detection of Colorectal Cancer in Blood Shannon Payne
14:35:00 Multiplexed Analysis of Glycan Variation on Serum Proteins Using An Antibody Array for Biomarker Profiling Bryce P Nelson
15:00:00 MAIN CONFERENCE : Conference Registration
15:00:00 Close of Workshop
16:00:00 Welcoming Remarks from Conference Director Julia Boguslavsky
16:10:00 Chairperson’s Opening Remarks
16:15:00 Use of Biomarkers and Translational Science to Accelerate and Improve Oncology Drug Development: Opportunities and Roadblocks J Carl Barrett
16:45:00 To be Announced
17:15:00 Reception with Exhibit and Poster Viewing
Tuesday, January 27, 2009
07:30:00 Sponsored Presentation (Opportunity Available) or Morning Coffee
08:30:00 COMBINATION THERAPIES : Combination Approaches for the Treatment of Solid Tumors: Opportunities and Obstacles in the Era of Targeted Therapy Jon M Wigginton
09:00:00 NEW TARGETS : To be Announced
09:30:00 Sponsored by ALMAC Diagnostics : Enabling Personalized Medicine From FFPE Tissue Austin Tanney
09:45:00 Sponsored by Definiens : To Be Announced
10:00:00 Coffee Break with Exhibit and Poster Viewing
11:00:00 MOLECULAR DIAGNOSTICS : To be Announced
11:30:00 COMPANION DIAGNOSTICS : The Potential Impact of Recently Approved and Emerging Molecular Diagnostics in Drug-Diagnostics Co-Development Francis Kalush
12:00:00 New Presentation
12:00:00 BETTER in vitro MODELS : Employing Brain Tumor Stem-Like Cells for Drug Testing and Drug Development Gregory J Riggins
12:00:00 New Presentation
12:30:00 Lunch on your own
14:00:00 BETTER in vivo MODELS : Mouse Cancer Models in Translation: Past, Present and Future Glenn Merlino
14:30:00 BIOMARKERS TO PREDICT DRUG RESPONSE : Matching Oncology Drugs with Patient Benefit: Preclinical and Clinical Discovery of Predictive Markers of Therapeutic Response Garret Hampton
15:00:00 Sponsored Presentations (Opportunities Available)
15:30:00 Refreshment Break with Exhibit and Poster Viewing
16:30:00 CANCER BIOLOGICS : Title to be Announced Bahija Jallal
17:00:00 PHASE 0 CLINICAL TRIALS : Risk-Based Compliance for Production of Agents for Phase 0 Studies John A Gilly
17:30:00 TRANSLATIONAL IMAGING : Translational Molecular Imaging: Oncology Syed Mahmood
18:00:00 Close of Day
Wednesday, January 28, 2009
07:30:00 Sponsored Presentation (Opportunity Available) or Morning Coffee
08:30:00 VECTIBIX : The KRAS Signaling Pathway Biomarker in Oncology: From Prognostic to Predictive Scott D Patterson
09:00:00 VANDETANIB : Pretreatment Circulating VEGF Levels as A Predictive Biomarker of Efficacy in NSCLC Patients Treated with Vandetanib Anderson Ryan
09:30:00 SUNITINIB : Guidance Toward Sunitinib Clinical Development Strategy through Translational Research Approaches James Christensen
10:00:00 Sponsored Presentations (Opportunities Available)
10:30:00 Coffee Break with Poster and Exhibit Viewing
11:30:00 TARCEVA : Incorporation of Biomarkers into Tarceva Clinical Trials Frank Richardson
12:00:00 To be Announced
12:30:00 Lunch on Your own
14:00:00 Development and Integration of Biomarkers into Clinically Useful Diagnostics Anne Marie Martin
14:30:00 Moving a New Technology into the Routine Lab: Validation and Education Challenges Lawrence Oliver
15:00:00 Molecular Diagnostics Laboratories (MoDEL): A Program to Support Cancer Biomarker Clinical Assay Development J Milburn Jessup
15:30:00 Networking Refreshment Break
16:00:00 Circulating Tumor Cell Assays: A Prognostic and Predictive Factor For Breast, Prostate And Colon Cancer Herbert A Fritsche
16:30:00 Biomarker Assay Development and Validation: An Epiphany for Drug Development and the Management of Patients with Cancer Martin Fleisher
17:00:00 Close of Conference
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.